New catheter coating could cut dialysis complications
NCT ID NCT07655544
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests a new dialysis catheter coated with Endexo technology, designed to resist blood clots and reduce infections. Researchers will compare its performance to older catheters in 50 adults with end-stage kidney disease. If successful, it could improve quality of life and lower healthcare costs for dialysis patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BioFlo Duramax catheter with Endexo technology
- What this could lead to
- If this works, it could mean fewer blocked catheters and infections for people on dialysis, making treatment smoother and safer.
- What could go wrong
- This is a small pilot study with only 50 people, comparing to past data rather than a direct head-to-head test. The new catheter may not perform better in larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIALYSIS ACCESS DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of Vienna
Vienna, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which nerve block offers better pain control for dialysis access surgery?
- Dialysis duel: does higher fluid volume or lower sodium improve patient outcomes?
- Could a milk protein help dialysis patients fight anemia?
- Could squeezing a ball make port needle changes less painful?
- Dialysis dilemma: catheter or fistula for the elderly?
- New dialysis gadget aims to clean blood better and boost life quality